ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $4,599,000 | -31.3% | 113,773 | -2.3% | 0.18% | -10.4% |
Q2 2015 | $6,699,000 | -11.9% | 116,403 | -2.6% | 0.20% | -7.4% |
Q1 2015 | $7,607,000 | -49.4% | 119,473 | -51.0% | 0.22% | -48.3% |
Q4 2014 | $15,043,000 | +31.1% | 243,653 | -17.5% | 0.42% | +37.7% |
Q3 2014 | $11,471,000 | +10.2% | 295,413 | -2.3% | 0.30% | +19.6% |
Q2 2014 | $10,412,000 | -27.8% | 302,243 | -9.5% | 0.26% | -18.8% |
Q1 2014 | $14,423,000 | +0.6% | 333,799 | -7.3% | 0.31% | +2.6% |
Q4 2013 | $14,343,000 | +0.7% | 360,020 | -5.1% | 0.31% | +1.3% |
Q3 2013 | $14,242,000 | – | 379,376 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |